17
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Recombinant Human Erythropoietin in the Treatment of Myelodysplastic Syndromes-Response Patterns

, , &
Pages 149-152 | Received 30 Dec 1993, Published online: 01 Jul 2009

References

  • Mittelman M. Recombinant erythropoietin in myelo-dysplastic syndromes—Whom to treat and how? More questions than answers. Acta Haematol 1994, in press
  • Ghio R., Balleari E., Ballestrero A., Gatti A., Mareni C., Massa G., Patrone F., Sessarego M., Timitilli S. Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes. Acta Haematol 1994, in press
  • Mohr B., Herrmann R., Huhn D. Recombinant human erythropoietin in patients with myelodysplastic syndromes and myelofibrosis. Acta Haematol 1994, in press
  • Spiriti M. A. A., Petti M.C., Latagliata R., Avvisati G., DeGregoris S., Proia S., Fazi P., Jaalouk G., Mancini M., Spadea A., Villa R., Mandelli F. Is recombinant human erythropoietin treatment in myelodysplastic syndromes worthwhile?. Leukemia and Lymphoma 1993; 9: 79–83
  • Mittelmann M., Floru S., Djaldetti M. Subcutaneous erythropoietin for the treatment of refractory anemia in hematologic disorders. Blood 1992; 80: 841
  • Pedrazzini A. Current and potential applications for erythropoietin. Acta Haematol. 1992; 87(Suppl.)2–3
  • Stein R.S., Abels R.I., Krantz S.B. Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes. Blood 1991; 78: 1658–1663
  • Bowen D., Culligan D., Jacobs A. The treatment of anemia in the myelodysplastic syndromes with recombinant human erythropoietin. Br. J. Haematol. 1991; 77: 419–423
  • Van Kamp H., Prinsze-Postema T.C., Kluin P.M., Den Ottolander G.J., Beverstock G.C., Willemze R., Fibbe W.E. Effects of subcutaneously administered human recombinant erythropoietin on erythropoiesis in patients with myelodysplasia. Br. J. Haematol. 1991; 78: 488–493
  • Casadevall N., Belanger C., Goy A., Varet B., Lang J., Poisson D. High dose recombinant human erythropoietin administered intravenously for the treatment of anemia of myelodysplastic syndromes. Acta Haematol. 1992; 87(Suppl.)25–27
  • Vreugdenhil G., Smeets M., Feelders R.A., van Eijk H.G. Iron chelators may enhance erythropoiesis by increasing iron delivery to haematopoietic tissue and erythropoietin response in iron loading anemia. Acta Haematol. 1993; 89: 57–60

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.